COVID-19 Updates
From the Journals
What do early remdesivir data suggest?
Data are ‘almost uninterpretable,’ says one drug researcher.
From the Journals
Remdesivir tops list of promising COVID-19 treatments in review of nearly 300 trials
Hydroxychloroquine data have “major limitations,” and corticosteroids are not recommended for supportive care.
From the Journals
Troponins touted as ‘ally’ in COVID-19 triage, but message is nuanced
A consequence of not measuring hs-cTn may be to “ignore the plethora of ischemic and nonischemic causes of myocardial injury related to COVID-19...
Commentary
COVID-19 pandemic brings unexpected pediatric consequences
Feature
ASH tackles COVID-19 with hematology-related FAQ, promotes new registries
Latest News
ABIM grants MOC extension
Those in their grace year will also be afforded an additional grace year in 2021.
Opinion
COVID 19: Confessions of an outpatient psychiatrist during the pandemic
It seems that some glitches would be inevitable. With a sudden shift to videoconferencing in private psychiatric practices, there were bound to be...
Opinion
COVID-19: What now?
With great reluctance, I must trot out a hoary old cliché: Hope for the best, but plan for the worst.
Latest News
Presymptomatic or asymptomatic? ID experts on shifting terminology
They also discussed the growing realization of racial disparities in COVID-19.
Latest News
COVID-19 hits physician couple: Dramatically different responses
Their story, one of two people living together but with such different responses to the infection, illustrates how much is still to be learned...
News
Doing things right vs. doing the right things
There has been inconsistent guidance in regard to the containment of COVID-19 within health care systems.